Female infertility associated with the FMR1 gene premutation

1. National Center for Biotechnology Information. FMR1 fragile X messenger ribonucleoprotein 1 [Homo sapiens (human)]. Gene ID: 2332. Available at: https://www.ncbi.nlm.nih.gov/gene/2332
2. Hunter J.E., Berry-Kravis E., Hipp H., Todd P.K., Adam M.P., Feldman J. et al. FMR1 Disorders. In: Adam M.P., eds. GeneReviews®. Seattle (WA): University of Washington; 1998. Updated May 16, 2024.
3. Nelson L.M., Covington S.N., Rebar R.W. An update: spontaneous premature ovarian failure is not an early menopause. Fertil. Steril. 2005; 83(5): 1327-32. https://dx.doi.org/10.1016/j.fertnstert.2004.11.059
4. Tassone F., Protic D., Allen E.G., Archibald A.D., Baud A., Brown T.W. et al. Insight and recommendations for fragile X-premutation-associated conditions from the Fifth International Conference on FMR1 Premutation. Cells. 2023; 12(18): 2330. https://dx.doi.org/10.3390/cells12182330
5. Hessl D., Rosselot H., Miller R., Espinal G., Famula J., Sherman S.L. et al. The International fragile X premutation registry: building a resource for research and clinical trial readiness. J. Med. Genet. 2022; 59(12): 1165-70. https://dx.doi.org/10.1136/jmedgenet-2022-108568
6. Рштуни С.Д., Зарецкая Н.В., Кузнецова М.В., Марченко Л.А. Особенности наследования тринуклеотидных CGG повторов в гене FMR1 от женщин с преждевременной недостаточностью яичников: серия случаев. Акушерство и гинекология. 2023; 3: 91-8. [Rshtuni S.D., Zaretskaya N.V., Kuznetsova M.V., Marchenko L.A. FMR1 inherited from women with premature ovarian failure: case series. Obstetrics and Gynecology. 2023; (3): 91-8 (in Russian)]. https://dx.doi.org/10.18565/aig.2022.285
7. Allen E.G., Sullivan A.K., Marcus M., Small C., Dominguez C., Epstein M.P. et al. Examination of reproductive aging milestones among women who carry the FMR1 premutation. Hum. Reprod. 2007; 22(8): 2142-52. https://dx.doi.org/10.1093/humrep/dem148
8. De Caro J.J., Dominguez C., Sherman S.L. Reproductive health of adolescent girls who carry the FMR1 premutation: expected phenotype based on current knowledge of fragile x-associated primary ovarian insufficiency. Ann. NY Acad. Sci. 2008; 1135: 99-111. https://dx.doi.org/10.1196/annals.1429.029
9. Stone W.L., Basit H., Shah M., Los E. Fragile X Syndrome. 2023 Oct 28. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
10. Hessl D., Rosselot H., Miller R., Espinal G., Famula J., Sherman S.L. et al. The International fragile X premutation registry: building a resource for research and clinical trial readiness. J. Med. Genet. 2022; 59(12): 1165-70. https://dx.doi.org/10.1136/jmedgenet-2022-108568
11. Hipp H.S., Charen K.H., Spencer J.B., Allen E.G., Sherman S.L. Reproductive and gynecologic care of women with fragile X primary ovarian insufficiency (FXPOI). Menopause. 2016; 23(9): 993-9. https://dx.doi.org/10.1097/GME.0000000000000658
12. Rose B.I., Brown S.E. An explanation of the mechanisms underlying fragile X-associated premature ovarian insufficiency. J. Assist. Reprod. Genet. 2020; 37(6): 1313-22. https://dx.doi.org/10.1007/s10815-020-01774-x
13. Friedman-Gohas M., Elizur S.E., Dratviman-Storobinsky O., Aizer A., Haas J., Raanani H. et al. FMRpolyG accumulates in FMR1 premutation granulosa cells. J. Ovarian. Res. 2020; 13(1): 22. https://dx.doi.org/10.1186/s13048-020-00623-w
14. Meng L., Jan S.Z., Hamer G., van Pelt A.M., van der Stelt I., Keijer J. et al. Preantral follicular atresia occurs mainly through autophagy, while antral follicles degenerate mostly through apoptosis. Biol Reprod. 2018; 99(4): 853-63. https://dx.doi.org/10.1093/biolre/ioy116
15. Conca Dioguardi C., Uslu B., Haynes M., Kurus M., Gul M., Miao D.Q. et al. Granulosa cell and oocyte mitochondrial abnormalities in a mouse model of fragile X primary ovarian insufficiency. Mol. Hum. Reprod. 2016; 22(6): 384-96. https://dx.doi.org/10.1093/molehr/gaw023
16. Fink D.A., Nelson L.M., Pyeritz R., Johnson J., Sherman S.L., Cohen Y. et al. Fragile X associated primary ovarian insufficiency (FXPOI): case report and literature review. Front. Genet. 2018; 9: 529. https://dx.doi.org/10.3389/fgene.2018.00529
17. Popat V.B., Vanderhoof V.H., Calis K.A., Troendle J.F., Nelson L.M. Normalization of serum luteinizing hormone levels in women with 46, XX spontaneous primary ovarian insufficiency. Fertil. Steril. 2008; 89(2): 429-33. https://dx.doi.org/10.1016/j.fertnstert.2007.02.032
18. Sonigo C., Mayeur A., Sadoun M., Pinto M., Benguigui J., Frydman N. et al. What is the threshold of mature oocytes to obtain at least one healthy transferable cleavage-stage embryo after preimplantation genetic testing for fragile X syndrome? Hum. Reprod. 2021; 36(11): 3003-13. https://dx.doi.org/10.1093/humrep/deab214
19. Hutchinson A.P., Pereira N., Lilienthal D.P., Coveney S., Lekovich J.P., Elias R.T. et al. Impact of FMR1 pre-mutation status on blastocyst development in patients undergoing pre-implantation genetic diagnosis. Gynecol. Obstet. Invest. 2018; 83(1): 23-8. https://dx.doi.org/10.1159/000455849
20. Fernández R.M., Peciña A., Lozano-Arana M.D., Sánchez B., García-Lozano J.C., Borrego S. et al. Clinical and technical overview of preimplantation genetic diagnosis for fragile X syndrome: experience at the University Hospital Virgen del Rocio in Spain. Biomed. Res. Int. 2015; 2015: 965839. https://dx.doi.org/10.1155/2015/965839
21. Liu X.S., Wu H., Krzisch M., Wu X., Graef J., Muffat J. et al. Rescue of fragile X syndrome neurons by DNA methylation editing of the FMR1 gene. Cell. 2018; 172(5): 979-92.e6. https://dx.doi.org/10.1016/j.cell.2018.01.012

Received 14.05.2025

Accepted 08.08.2025